| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |